Zura Bio Ltd.Preferred / convertible

13F holders, Q1 2024 (March 31)
13holders
$0.27avg. 13F price*

At the end of Q1 2024, 13 institutions reported holding Zura Bio Ltd. in their 13F filings. The largest holders were Boussard & Gavaudan Investment Management LLP ($58K), Hudson Bay Capital Management LP ($54K) and Kim, LLC ($34K).

Company
Zura Bio Ltd.
CUSIP
G9TY5A119
Latest filing quarter
Q2 2024

History

Number of 13F holders

051015 Q1 2024: 13Q1 2024Q2 2024: 14Q2 2024

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions0$0
Exits1$59K

Ownership 13 holders

Boussard & Gavaudan Investment Management LLP — No change 187,500 $58K
Hudson Bay Capital Management LP — No change 199,975 $54K
Kim, LLC — No change 125,000 $34K
Meteora Capital, LLC — Reduce -25.4% 97,231 $26K
Whitebox Advisors LLC — No change 75,000 $20K
Polar Asset Management Partners Inc. — Reduce -50.0% 75,071 $18K
Walleye Capital LLC — No change 56,608 $15K
Clear Street LLC — No change 45,675 $12K
Walleye Trading LLC — No change 31,842 $9K
AQR Arbitrage LLC — Reduce -7.0% 26,858 $7K
Warberg Asset Management LLC — No change 25,818 $7K
Two Sigma Investments, LP — No change 21,500 $6K
Wolverine Asset Management LLC — Reduce -90.1% 327 $88

"% of holder's portfolio" is ZURA BIO LTD's weight in each manager's 13F, not the share of Zura Bio Ltd. the manager owns.